M28 Capital Management as of March 31, 2023
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 14 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences SHS (WVE) | 34.0 | $30M | 7.0M | 4.33 | |
| Rocket Pharmaceuticals (RCKT) | 14.0 | $12M | 722k | 17.13 | |
| Adagio Therapeutics (IVVD) | 12.5 | $11M | 9.2M | 1.20 | |
| Tg Therapeutics (TGTX) | 5.8 | $5.1M | 340k | 15.04 | |
| Springworks Therapeutics (SWTX) | 5.8 | $5.1M | 198k | 25.74 | |
| Bridgebio Pharma (BBIO) | 5.7 | $5.1M | 305k | 16.58 | |
| Ionis Pharmaceuticals (IONS) | 5.1 | $4.5M | 126k | 35.74 | |
| Stoke Therapeutics (STOK) | 5.0 | $4.4M | 533k | 8.33 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 4.6 | $4.1M | 1.9M | 2.13 | |
| Curis Com New | 3.0 | $2.7M | 4.5M | 0.60 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.9 | $1.7M | 67k | 25.40 | |
| Atara Biotherapeutics (ATRA) | 1.4 | $1.3M | 439k | 2.90 | |
| Silence Therapeutics Ads (SLN) | 1.0 | $905k | 146k | 6.20 | |
| Neximmune | 0.1 | $51k | 133k | 0.38 |
